Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
ArcherDx
is defunct.
Acquired by Invitae, Oct 2020, $1.4B; Spun out of Enzymatics after Qiagen acquired
------------------
If you believe any of this information is incorrect, please
let us know
.